Gene · 79813
NIH grants1,962
NIH grants whose papers are about the gene, through NIH's grant-paper links.
401 to 420 of 1,962
Download this page as JSON| Grant | Title | EHMT1 papers | Newest fiscal year |
|---|---|---|---|
| K23HD101646 | Preparing for a Clinical Trial in Kabuki Syndrome- Characterization of Cognitive and Neuroanatomical Features and Pilot Treatment Trial | 1 | 2024 |
| K99HL170075 | Identification of Novel Epigenetic Regulators of lymphocyte Development | 1 | 2024 |
| KL2TR001413 | Institutional Career Development | 1 | 2024 |
| P01CA171983 | Targeted Sphingolipid Metabolism for Treatment of AML | 1 | 2024 |
| P20GM104320 | Nebraska Center for the Prevention of Obesity Diseases through Dietary Molecules | 1 | 2024 |
| P30ES000002 | Harvard Chan School NIEHS Center for Environmental Health | 1 | 2024 |
| P30ES030283 | University of Louisville Center for Integrative Environmental Health Sciences | 1 | 2024 |
| P41GM103504 | National Resource for Network Biology (NRNB) | 1 | 2024 |
| P50CA098131 | SPORE in Breast Cancer | 1 | 2024 |
| P50HD104458 | FMRP-mediated Regulation in Human Brain Development and Therapeutic Advancement | 1 | 2024 |
| R01AA028924 | Microglia Activation and TLR-induced Neurodegeneration by Alcohol Promotes Progression of Alzheimer Pathology | 1 | 2024 |
| R01AG063846 | Harnessing Single Cell Epigenome-wide profiling of Myeloid cells to Compare and Contrast Alzheimer's from HIV-Associated Cognitive Dysfunction | 1 | 2024 |
| R01AG065611 | Towards a better understanding of genetic architecture of Alzheimer's disease with human iPSC models | 1 | 2024 |
| R01AG067063 | ApoE, ABCA1 and endosomal dysregulation in AD | 1 | 2024 |
| R01AI149699 | Multi-omic dissection of the transcriptional, epigenetic, and proteomic signatures of cells infected with latent HIV | 1 | 2024 |
| R01AR077615 | Epigenetic enhancer control in maintaining homeostasis and preventing carcinogenesis in the epidermis | 1 | 2024 |
| R01CA190429 | RNA epigenetic regulation of cancer metabolism | 1 | 2024 |
| R01CA236780 | Aberrant tumor metabolism that enables AR antagonist-resistant prostate cancer | 1 | 2024 |
| R01CA236890 | Linking nucleotide and amino acid metabolism to cholesterol synthesis by MYCN | 1 | 2024 |
| R01CA240910 | Cooperation of SF3B1 mutations and ATM deletions in the pathogenesis of chronic lymphocytic leukemia | 1 | 2024 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79813/grants?page=21